[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 48, "title": "CEO & Chairman of the Board", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 491961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurie A. Myers M.B.A., Ph.D.", "age": 66, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 415167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 59, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Callahan CPA", "age": 52, "title": "Senior VP, CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 65, "title": "Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.832, "open": 2.36, "dayLow": 1.83, "dayHigh": 2.83, "regularMarketPreviousClose": 2.832, "regularMarketOpen": 2.36, "regularMarketDayLow": 1.83, "regularMarketDayHigh": 2.83, "beta": -1.077, "forwardPE": -1.0493562, "volume": 503612, "regularMarketVolume": 503612, "averageVolume": 56507, "averageVolume10days": 80952, "averageDailyVolume10Day": 80952, "bid": 1.78, "ask": 2.72, "bidSize": 200, "askSize": 200, "marketCap": 2130800, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 187.2, "fiftyDayAverage": 5.569092, "twoHundredDayAverage": 26.927197, "currency": "USD", "enterpriseValue": 540948, "floatShares": 498497, "sharesOutstanding": 871493, "sharesShort": 16587, "sharesShortPriorMonth": 17033, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.019, "shortRatio": 0.19, "shortPercentOfFloat": 0.0217, "impliedSharesOutstanding": 871493, "bookValue": 7.703, "priceToBook": 0.3174088, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -22502536, "trailingEps": -234.24, "forwardEps": -2.33, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.026, "52WeekChange": -0.9815444, "SandP52WeekChange": 0.19031036, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CING", "underlyingSymbol": "CING", "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "firstTradeDateEpochUtc": 1638973800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bf898f9d-c1c1-3f31-9c96-a5b2c0f73dcd", "messageBoardId": "finmb_1674914781", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.445, "targetHighPrice": 20.0, "targetLowPrice": 8.0, "targetMeanPrice": 14.0, "targetMedianPrice": 14.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 1113830, "totalCashPerShare": 2.211, "ebitda": -21211522, "totalDebt": 422809, "quickRatio": 0.524, "currentRatio": 1.214, "debtToEquity": 13.147, "returnOnAssets": -2.15855, "returnOnEquity": -13.647281, "freeCashflow": -11954895, "operatingCashflow": -20204442, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-10"}]